DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Anastasilakis AD, Goulis DG, Polyzos SA, Gerou S, Koukoulis G, Kita M, Avramidis A.
Serum osteoprotegerin and RANKL are not specifically altered in women with postmenopausal osteoporosis treated with teriparatide or risedronate: a randomized controlled trial.
Horm Metab Res 2008; 40: 281-285
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.